Phase-Transfer Catalyzed Alkylation and Cycloalkylation of 3-Substituted-1H-pyrazol-2-in-5-ones in the Absence or Presence of Carbon Disulphide
摘要:
PTC-alkylation of 3-substituted-1H-pyrazol-2-in-5-ones by different organohalogen reagents at 25degreesC in the presence of tetrabutylammonium bromide as-catalyst was investigated either in the absence or presence of CS2. This work aims to study the comparative reactivity of N-versus O-versus C-alkylation and cycloalkylation.
INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME
申请人:Abbott Laboratories
公开号:EP2117526A2
公开(公告)日:2009-11-18
[EN] INHIBITORS OF DIACYLGLYCEROL O-ACYLOTRANSFERASE TYPE 1 ENZYME<br/>[FR] INHIBITEURS DE L'ENZYME DIACYLGLYCÉROL O-ACYLOTRANSFÉRASE DE TYPE 1
申请人:ABBOTT LAB
公开号:WO2008067257A2
公开(公告)日:2008-06-05
(EN) Compounds of formula (I), or a pharmaceutically acceptable salt, prodrug, salt of a prodrug, or a combination thereof. Pharmaceutical compositions of formula (I) and related methods for treating or preventing metabolic diseases or conditions.(FR) L'invention concerne des composés représentés par la formule (I), ou un sel pharmaceutiquement acceptable, un promédicament, un sel de promédicament ou une combinaison de ceux-ci. L'invention concerne également des compositions pharmaceutiques de formule (I) et des méthodes associées pour traiter ou prévenir les maladies ou les troubles métaboliques.